Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationships between p16 gene promoter methylation and clinicopathologic features of colorectal cancer: a meta-analysis of 27 cohort studies.

DNA and cell biology - 1 Oct 2014

Chen Yan-Zhi, Liu Dan, Zhao Yu-Xia, Wang He-Tong, Gao Ya, Chen Ying

Abstract excerpt

Many existing studies have demonstrated that p16 promoter methylation might be correlated with the clinicopathologic features of colorectal cancer (CRC), but individually published results are inconclusive. This meta-analysis aimed to derive a more precise estimation of the relationships between p16 promoter methylation and the clinicopathologic features of CRC. We searched the CISCOM, CINAHL, Web of Science,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinase Inhibitor p16

Share to DNA Methylation

Share to Genes, p16

Share to Lymphatic Metastasis

Share to Neoplasm Grading

Share to Promoter Regions, Genetic

Source

Identifiers

PMID: 24979649
DOI: 10.1089/dna.2013.2253

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationships between p16 gene promoter methylation and clinicopathologic features of colorectal cancer: a meta-analysis of 27 cohort studies.PMID 24979649Read ↗

The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological stagingSemantic proximity Read ↗

Aberrant promoter methylation of RASSF1A gene may be correlated with colorectal carcinogenesis: a meta-analysis.Semantic proximity Read ↗

Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma.Semantic proximity Read ↗

Molecular detection of p16 promoter methylation in the serum of colorectal cancer patientsSemantic proximity Read ↗

Association between P16INK4a Promoter Methylation and Ovarian Cancer: A Meta-Analysis of 12 Published Studies.Semantic proximity Read ↗

p16 protein is upregulated in a stepwise fashion in colorectal adenoma and colorectal carcinoma.Semantic proximity Read ↗

Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis.Semantic proximity Read ↗

Promoter methylation of the RASSF1A gene may contribute to colorectal cancer susceptibility: a meta-analysis of cohort studies.Semantic proximity Read ↗

Multiple gene-specific DNA methylation in blood leukocytes and colorectal cancer risk: a case-control study in ChinaSemantic proximity Read ↗

p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survivalSemantic proximity Read ↗

Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patientsSemantic proximity Read ↗

Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.